Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,840,854
-
Share change
-
-1,579,641
-
Total reported value
-
$38,602,556
-
Put/Call ratio
-
95%
-
Price per share
-
$3.26
-
Number of holders
-
68
-
Value change
-
-$5,136,200
-
Number of buys
-
28
-
Number of sells
-
37
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2022
As of 30 Sep 2022,
Humacyte, Inc. - COM (HUMA) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,840,854 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., York Capital Management Global Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, Prescott General Partners LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, LPL Financial LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.